The choice of agents for the initial treatment of metatstatic RCCa has become more complex with the recent evidence and approvals in this disease. For newly Dx good prognosisi pts I choose either Sunitinib or Pazopanib as there is yet no evidence of something being superior. For intermediate and poo...